統合失調症のスペクトル障害における認知制御は,単発的な運動ではなく,長期的な運動活動と関連している
Philipp Mench1, T Koppius2, J Ewen3
1Department of Psychiatry and Psychotherapy, University of Lübeck, Ratzeburger Allee 160, 23538, Lübeck, Germany. philipp.mench@student.uni-luebeck.de.
European archives of psychiatry and clinical neuroscience
|September 6, 2025
まとめ
統合失調症スペクトル障害 (SSD) の患者の認知機能は,一度の有酸素運動により改善されませんでした. しかし,長期にわたるより高い身体能力は,SSD患者のよりよい認知コントロールと関連していました.
科学分野:
- 神経科学
- 精神科
- 運動 生理学
背景:
- 統合失調症スペクトル障害 (SSD) は,重大な認知障害と関連しています.
- 認知機能はSSDの全般的な健康状態に不可欠です.
- 以前の研究によると 身体運動は 健康な人群の認知能力を高めることが示されています
研究 の 目的:
- SSD患者の認知機能に対する有酸素運動の急性効果を調査する.
- SSD患者と健康な対照群の間の運動に対する認知反応を比較する.
- SSDにおける長期的な身体的健康,運動活動,認知能力の関係を探求する.
主な方法:
- 単独で調整されたエアロビック運動が実施された.
- 認知機能の評価は,運動前と運動後の眼運動 (サッカードとスムーズな追及眼運動) を用いて行われました.
- 長期の身体能力と身体活動のレベルは,無酸素的値テストと自己報告によって測定されました.
主要な成果:
- SSDの患者は,対照群と比較して,アンチサケード精度とスムーズな追跡眼運動 (SPEM) の欠陥を示した.
- 運動直後にサッカードまたはSPEMのパフォーマンスの有意な改善は観察されなかった.
- SSD患者における長期の身体的健康と運動活動のレベルが高くなり,アンチサッカードエラーの減少と相関していた.
結論:
- 一回のエアロビック運動は,SSD患者の認知機能を急激に改善しません.
- 長期的な身体活動とフィットネスは,SSDにおけるよりよい認知コントロールと関連している可能性があります.
- 持続的な運動介入に関するさらなる研究は,SSDにおける認知欠陥に対する潜在的な補足療法として正当化されています.
さらに関連する動画
関連する概念動画
Positive Symptoms of Schizophrenia: Hallucinations and Delusions
215
Schizophrenia is a complex mental health disorder that can manifest with various positive symptoms, including thought, movement, and behavior disorders. These symptoms significantly disrupt cognitive and motor functions, leading to profound effects on an individual's ability to engage with the world.
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
Thought Disorders
Disorganized and unusual thought processes mark thought disorders in schizophrenia. One key feature is disorganized speech, where an individual's conversation includes...
215
Negative and Cognitive Symptoms of Schizophrenia
118
Negative symptoms of schizophrenia indicate a reduction or absence of typical behaviors and emotional responses found in healthy individuals, while positive symptoms reflect an excess or distortion of normal functioning.
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
Negative Symptoms
Negative symptoms of schizophrenia manifest as deficits in normal emotional and behavioral functioning, profoundly impacting daily life. Individuals with schizophrenia often display a flat affect, characterized by a near-total absence of emotional expression,...
118
Psychosis and Antipsychotic Drugs: Overview
452
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
452
Schizophrenia
215
Schizophrenia, a term introduced by Swiss psychiatrist Eugen Bleuler in 1911, describes a severe psychological disorder marked by profound disruptions in attention, thought processes, language, emotion, and interpersonal relationships. The core feature of schizophrenia is psychosis — a state characterized by a fundamental detachment from reality. This disconnection manifests through distorted logic, impaired perception, and atypical behavior, severely affecting the lives of those...
215
Psychosis: Goals of Pharmacotherapy
208
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
208
Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
941
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
941


